S&P 500 7,686 +0.43% Nasdaq 26,371 +1.50% Dow Jones 53,186 -0.43% FTSE 100 10,824 +0.07% DAX 26,258 +0.58% Nikkei 225 66,216 -0.07% Hang Seng 25,300 -0.83% WTI Crude 86.65 +5.38% Gold 4,487 -2.41% US 10-Year Treasury Yield 4.758 +2.57% S&P 500 7,686 +0.43% Nasdaq 26,371 +1.50% Dow Jones 53,186 -0.43% FTSE 100 10,824 +0.07% DAX 26,258 +0.58% Nikkei 225 66,216 -0.07% Hang Seng 25,300 -0.83% WTI Crude 86.65 +5.38% Gold 4,487 -2.41% US 10-Year Treasury Yield 4.758 +2.57%

LATEST

Hindustan Copper after OFS: Pros and cons investors should know●Bessent reportedly tells Russia no economic relief until Ukraine war ends as Europe snubs Moscow at G20●Deepa Jewellers IPO day 1: GMP signals 31% listing gain; should you apply for ₹460 crore issue?●Shein IPO debut disappoints: Fashion Giant tanks 10% on Hong Kong listing, valuation drops●Thai bank reportedly nears deal for DBS wealth unit●HDFC Bank share price hits 52-week low after gaining 2.5% on CEO resignation | What's next?●Indonesia signs 1,000-tonne rice MoU with Malaysia amid 38.6mn-tonne bumper harvest projection●Rays of Belief IPO Day 1: GMP signals 20% listing gain. Should you subscribe to ₹125 crore issue?●Hindustan Copper after OFS: Pros and cons investors should know●Bessent reportedly tells Russia no economic relief until Ukraine war ends as Europe snubs Moscow at G20●Deepa Jewellers IPO day 1: GMP signals 31% listing gain; should you apply for ₹460 crore issue?●Shein IPO debut disappoints: Fashion Giant tanks 10% on Hong Kong listing, valuation drops●Thai bank reportedly nears deal for DBS wealth unit●HDFC Bank share price hits 52-week low after gaining 2.5% on CEO resignation | What's next?●Indonesia signs 1,000-tonne rice MoU with Malaysia amid 38.6mn-tonne bumper harvest projection●Rays of Belief IPO Day 1: GMP signals 20% listing gain. Should you subscribe to ₹125 crore issue?●

Asia

Symbiotec Pharmalab shares to list today; GMP signals 19% listing gain

Markets-Economic Times · 1h ago · 🇮🇳 India

Symbiotec Pharmalab shares to list today; GMP signals 19% listing gain

The Symbiotec Pharmalab IPO plans to channel Rs 112.50 crore towards the prepayment and/or repayment, fully or partially, of select outstanding borrowings, helping strengthen the company’s balance sheet and potentially reduce its debt burden.

Read the full story at Markets-Economic Times →

More Asia

Hindustan Copper after OFS: Pros and cons investors should know

mint - markets · 29m ago

US Treasury Rules Out Sanctions Relief for Russia Until Ukraine War Ends

EUROS · 37m ago

Deepa Jewellers IPO day 1: GMP signals 31% listing gain; should you apply for ₹460 crore issue?

mint - markets · 38m ago

Shein IPO debut disappoints: Fashion Giant tanks 10% on Hong Kong listing, valuation drops

mint - markets · 42m ago